• News
  • Out in Jan: 2nd Benchmark of pharma companies...
News - published on 19 Nov 2019

Out in Jan: 2nd Benchmark of pharma companies' actions on antibiotic resistance and access

The 2020 Antimicrobial Resistance Benchmark will be published in January next year. In this new report, the Access to Medicine Foundation will address unanswered questions about how the pharma industry is improving access to antibiotics and antifungals, while responding to rising rates of antimicrobial resistance (AMR). 

Explore further

Get in touch

Back to top |